Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries is currently trading at Rs. 841.50, up by 1.50 points or 0.18% from its previous closing of Rs. 840.00 on the BSE.

The scrip opened at Rs. 837.00 and has touched a high and low of Rs. 842.60 and Rs. 824.70 respectively. So far 65000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1200.70 on 07-Apr-2015 and a 52 week low of Rs. 748.15 on 26-Sep-2014.

Last one week high and low of the scrip stood at Rs. 903.00 and Rs. 815.30 respectively. The current market cap of the company is Rs. 201195.11 crore.

The promoters holding in the company stood at 54.71% while Institutions and Non-Institutions held 31.51% and 13.78% respectively.

In a bid to control costs that have spiralled since it bought Ranbaxy Laboratories, Sun Pharmaceutical Industries is reportedly looking to divest a manufacturing plant in Ireland.

The world’s fifth largest generic drugmaker has been working on resolving issues at Ranbaxy's India-based drug manufacturing sites, all of which have been banned from exporting to its largest market, the United States, over quality control issues.

Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business, economies of scale and an extremely skilled team enable the comapy to deliver quality products in a timely manner at affordable prices.